Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03721003
Other study ID # IPMISTBISCE
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date January 1, 2019
Est. completion date December 30, 2021

Study information

Verified date October 2018
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Intracranial pressure (ICP) is defined as the pressure inside the skull, and therefore, the pressure inside the brain tissue and the cerebrospinal fluid (CSF). The relationship between CSF and intracranial blood volumes is described by the Monroe Kellie doctrine; because the brain is incompressible, when the skull is intact, the sum of the volumes of brain, CSF, and intracranial blood is constant.


Description:

ICP >15 mmHg is considered to be elevated, and this is considered an important cause of secondary injury leading to irreversible brain injury and death. ICP monitoring is used in a number of conditions; traumatic brain injury, intracerebral haemorrhage, subarachnoid haemorrhage, hydrocephalus, malignant infarction, cerebral oedema, CNS infections, hepatic encephalopathy, to name a few, and in all of these conditions ICP monitoring in the light of other parameters can influence management for better outcomes.

There are 4 ways to monitor intracranial pressure:

1. An intra-parenchymal method, the catheter is placed into the brain parenchyma through a burr hole; it has a lower complication rate, lower infection rate, and no chance of catheter occlusion or leakage. Neurological injury is minimized because of the small diameter of the probe. In addition, malposition of the transducer has less impact on errors of measurement.

2. An intra-ventricular method, the catheter is placed into one of the ventricles (lat. Ventricle). The catheter can also be used for therapeutic CSF drainage and for administration of drugs.

3. Subdural method, this method is used if monitoring needs to be done right away. A hollow screw is inserted through a burr hole and placed through the Dura mater.

4. An epidural sensor is inserted between the skull and dural tissue. This procedure is less invasive than other methods.

ICP monitoring methods is associated with a number of complications. These include risk of infection, haemorrhage, obstruction, difficulty in placement, malposition, etc.

The use of an ICP monitor is associated with significantly lower mortality when compared with patients treated without an ICP monitor


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 32
Est. completion date December 30, 2021
Est. primary completion date January 1, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

1. Age >18

2. GCS < 8

3. patient with severe brain insult ( Marshall class II to IV)

4. patients admitted within 24 hours from the trauma time

Exclusion Criteria:

1. Patients admitted for surgery (ex; surgical EDH) .

2. patient diagnosed as brain death

Study Design


Intervention

Device:
ICP monitoring
4- Use the Touhy needle to tunnel under the scalp from the Burr Hole site to the desired MICROSENSOR exit site. 5- Place the tip of the MICROSENSOR in the Parenchyma through the puncture in the Dura

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Outcome

Type Measure Description Time frame Safety issue
Primary analyse role of ICP monitoring of patient with diffuse traumatic brain injury study the significance of application of ICP monitor on outcome of patients with diffuse traumatic brain injury using glascow coma scale The Glasgow Coma Scale (GCS) is a neurological scale which aims to give a reliable and objective way of recording the conscious state of a person for initial as well as subsequent assessment. A patient is assessed against the criteria of the scale, and the resulting points give a patient score between 3 (indicating deep unconsciousness) and either 14 (original scale) or 15 (more widely used modified or revised scale) one year
See also
  Status Clinical Trial Phase
Recruiting NCT04562844 - Assessment and Rehabilitation of Social Cognition in People With Traumatic Brain Injury N/A
Not yet recruiting NCT04574349 - Decompressive Craniectomy Following Trauma N/A
Active, not recruiting NCT04313712 - Pre-post Evaluation of the Safety and Efficacy of Ibogaine-Magnesium Therapy in Veterans With Repeated Blast Exposure
Recruiting NCT04212754 - Management and Outcomes Following Emergency Surgery for Traumatic Brain Injury
Recruiting NCT06370520 - Screening Emotions in Adolescents at the Hospital for mTBI
Completed NCT03822026 - Hyperventilation in Patients With Traumatic Brain Injury N/A
Not yet recruiting NCT04946747 - Detection and Prevention of Concussive Injuries With Smart Technology. N/A
Recruiting NCT03687528 - Platelet Inhibitor Treated Patients With Head Injury Trauma Meeting NICE Criteria : is the CT-scan Mandatory ?
Recruiting NCT04993495 - Study Evaluating the Potential Impact of a Hemorrhagic Risk Stratification Score in Patients With Mild Head Trauma
Active, not recruiting NCT05490576 - Tau And Connectomics In TES Study Phase 1
Completed NCT03870867 - The Emergency Department Falls Study
Completed NCT04225663 - A Meditation Intervention on Subconcussive Head Impacts N/A